$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

$zvra Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000143774921005785 Filed on March 12, 2021

Income Statement

Concept	2019 Q4	2019	2018 Q4
Revenue	$1.380M	$12.84M	$0.00
YoY Change
Cost Of Revenue		$10.00M
YoY Change
Gross Profit		$2.839M
YoY Change
Gross Profit Margin		22.11%
Selling, General & Admin	$1.380M	$10.82M	$2.960M
YoY Change	-53.38%	-21.25%	13.41%
% of Gross Profit		381.12%
Research & Development	$2.470M	$19.42M	$6.300M
YoY Change	-60.79%	-53.51%	13.8%
% of Gross Profit		683.87%
Depreciation & Amortization	$70.00K	$304.0K	$70.00K
YoY Change	0.0%	-6.17%	-22.22%
% of Gross Profit		10.71%
Operating Expenses	$5.790M	$19.42M	$9.270M
YoY Change	-37.54%	-65.27%	13.74%
Operating Profit		-$20.34M
YoY Change		-63.62%
Interest Expense	-$1.640M	$4.858M	$4.060M
YoY Change	-140.39%	-11.17%	181.16%
% of Operating Profit
Other Income/Expense, Net		-$4.207M
YoY Change		510.6%
Pretax Income	-$6.050M	-$24.54M	-$5.200M
YoY Change	16.35%	-56.63%	-50.93%
Income Tax	-$10.00K	-$22.00K	-$20.00K
% Of Pretax Income
Net Earnings	-$6.040M	-$24.52M	-$5.180M
YoY Change	16.6%	-56.57%	-50.97%
Net Earnings / Revenue	-437.68%	-191.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.890M	-$13.25M	-$3.238M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2019	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.200M	$3.220M	$21.70M
YoY Change	-85.25%	-85.14%	-48.58%
Cash & Equivalents	$3.217M	$3.220M	$18.41M
Short-Term Investments	$0.00	$0.00	$3.300M
Other Short-Term Assets	$1.500M	$1.560M	$2.100M
YoY Change	-28.57%	-18.32%	-25.0%
Inventory
Prepaid Expenses
Receivables	$1.681M	$1.870M	$0.00
Other Receivables	$184.0K	$0.00	$140.0K
Total Short-Term Assets	$6.972M	$6.630M	$23.72M
YoY Change	-70.61%	-72.05%	-48.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.471M	$3.010M	$1.753M
YoY Change	-16.09%	72.0%	-12.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets	$527.0K	$870.0K	$562.0K
YoY Change	-6.23%	-31.5%	172.82%
Total Long-Term Assets	$3.535M	$3.880M	$3.025M
YoY Change	16.86%	28.05%	-53.89%
TOTAL ASSETS
Total Short-Term Assets	$6.972M	$6.630M	$23.72M
Total Long-Term Assets	$3.535M	$3.880M	$3.025M
Total Assets	$10.51M	$10.51M	$26.75M
YoY Change	-60.72%	-60.71%	-49.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.140M	$4.910M	$3.715M
YoY Change	-69.31%	31.99%	70.65%
Accrued Expenses	$700.0K	$280.0K	$700.0K
YoY Change	0.0%	-93.95%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$200.0K	$240.0K	$3.500M
YoY Change	-94.29%	-93.24%	0.0%
Total Short-Term Liabilities	$5.431M	$5.430M	$12.00M
YoY Change	-54.76%	-54.75%	4.3%
LONG-TERM LIABILITIES
Long-Term Debt		$77.51M	$78.50M
YoY Change		-1.26%	-12.78%
Other Long-Term Liabilities	$168.0K	$2.020M	$689.0K
YoY Change	-75.62%	-28.11%	-13.22%
Total Long-Term Liabilities	$168.0K	$79.53M	$689.0K
YoY Change	-75.62%	-2.19%	-13.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.431M	$5.430M	$12.00M
Total Long-Term Liabilities	$168.0K	$79.53M	$689.0K
Total Liabilities	$84.96M	$84.96M	$93.31M
YoY Change	-8.95%	-8.95%	-15.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$245.7M		-$221.2M
YoY Change	11.09%		34.28%
Common Stock	$171.3M		$154.6M
YoY Change	10.76%		44.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$74.46M	-$74.46M	-$66.57M
YoY Change
Total Liabilities & Shareholders Equity	$10.51M	$10.51M	$26.75M
YoY Change	-60.72%	-60.71%	-49.01%

Cashflow Statement

Concept	2019 Q4	2019	2018 Q4
OPERATING ACTIVITIES
Net Income	-$6.040M	-$24.52M	-$5.180M
YoY Change	16.6%	-56.57%	-50.97%
Depreciation, Depletion And Amortization	$70.00K	$304.0K	$70.00K
YoY Change	0.0%	-6.17%	-22.22%
Cash From Operating Activities	-$3.100M	-$23.74M	-$14.99M
YoY Change	-79.32%	-56.21%	115.99%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	$26.00K	-$10.00K
YoY Change	0.0%	23.81%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$3.260M	$7.980M
YoY Change	-100.0%	-90.22%	-20.36%
Cash From Investing Activities	-$10.00K	$3.234M	$7.960M
YoY Change	-100.13%	-90.3%	-20.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-350.0K	4.939M	23.27M
YoY Change	-101.5%	-82.37%	-77666.67%
NET CHANGE
Cash From Operating Activities	-3.100M	-23.74M	-14.99M
Cash From Investing Activities	-10.00K	3.234M	7.960M
Cash From Financing Activities	-350.0K	4.939M	23.27M
Net Change In Cash	-3.460M	-15.56M	16.24M
YoY Change	-121.31%	-317.74%	434.21%
FREE CASH FLOW
Cash From Operating Activities	-$3.100M	-$23.74M	-$14.99M
Capital Expenditures	-$10.00K	$26.00K	-$10.00K
Free Cash Flow	-$3.090M	-$23.76M	-$14.98M
YoY Change	-79.37%	-56.18%	115.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	30000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	484000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	460000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	390000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	463000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	385000
CY2020Q4	us-gaap	Liabilities Liabilities	77621000
CY2019Q4	us-gaap	Liabilities Liabilities	84963000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11209000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10507000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7536000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	472000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5431000
CY2020	us-gaap	Short Term Lease Payments ShortTermLeasePayments	210000
CY2019	us-gaap	Short Term Lease Payments ShortTermLeasePayments	232000
CY2020	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	34000
CY2019	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	-22000
CY2020	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	23216
CY2019	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	6354
CY2020	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	10247
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-74456000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-66566000
CY2020	us-gaap	Sublease Income SubleaseIncome	106000
CY2019	us-gaap	Sublease Income SubleaseIncome	84000
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	10526
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	202000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-66412000
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001434647
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28376321
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	dei	Entity Public Float EntityPublicFloat	18500000
CY2020	dei	Entity Registrant Name EntityRegistrantName	KEMPHARM, INC
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2020	dei	Trading Symbol TradingSymbol	kmph
CY2019	kmph	Adjustment To Additional Paid In Capital Writeoff Of Deferred Offering Costs AdjustmentToAdditionalPaidInCapitalWriteoffOfDeferredOfferingCosts	116000
CY2020	kmph	Adjustment To Additional Paid In Capital Writeoff Of Deferred Offering Costs AdjustmentToAdditionalPaidInCapitalWriteoffOfDeferredOfferingCosts	121000
CY2020	kmph	Cash Paid In Lieu Of Fractional Shares In Connection With Reverse Stock Split Included In Accounts Payable And Accrued Expenses CashPaidInLieuOfFractionalSharesInConnectionWithReverseStockSplitIncludedInAccountsPayableAndAccruedExpenses	23000
CY2019	kmph	Cash Paid In Lieu Of Fractional Shares In Connection With Reverse Stock Split Included In Accounts Payable And Accrued Expenses CashPaidInLieuOfFractionalSharesInConnectionWithReverseStockSplitIncludedInAccountsPayableAndAccruedExpenses
CY2020	kmph	Commitment Shares Issued In Connection With Equity Line Of Credit Included In Deferred Offering Costs CommitmentSharesIssuedInConnectionWithEquityLineOfCreditIncludedInDeferredOfferingCosts	121000
CY2019	kmph	Commitment Shares Issued In Connection With Equity Line Of Credit Included In Deferred Offering Costs CommitmentSharesIssuedInConnectionWithEquityLineOfCreditIncludedInDeferredOfferingCosts	300000
CY2020	kmph	Consulting Fees Paid In Stock ConsultingFeesPaidInStock	202000
CY2019	kmph	Consulting Fees Paid In Stock ConsultingFeesPaidInStock
CY2019Q3	kmph	Convertible Preferred Stock Conversion Restriction Percentage Of Common Stock ConvertiblePreferredStockConversionRestrictionPercentageOfCommonStock	0.04985
CY2019Q4	kmph	Debt Instrument Convertible Minimum Conversion Price DebtInstrumentConvertibleMinimumConversionPrice	9.328
CY2020Q4	kmph	Debt Issuance Costs And Discount Gross DebtIssuanceCostsAndDiscountGross	585000
CY2019Q4	kmph	Debt Issuance Costs And Discount Gross DebtIssuanceCostsAndDiscountGross	2856000
CY2020Q4	kmph	Deferred Income Tax Assets Liabilities DeferredIncomeTaxAssetsLiabilities	70092000
CY2019Q4	kmph	Deferred Income Tax Assets Liabilities DeferredIncomeTaxAssetsLiabilities	67186000
CY2020	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense	817000
CY2019	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
CY2020	kmph	Deferred Offering Costs Writeoff DeferredOfferingCostsWriteoff
CY2019	kmph	Deferred Offering Costs Writeoff DeferredOfferingCostsWriteoff	116000
CY2020Q4	kmph	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	304000
CY2019Q4	kmph	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	120000
CY2020	kmph	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Tax Credit Research Percent EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRateTaxCreditResearchPercent
CY2020	kmph	Effective Income Tax Rate Reconciliation Return To Provision And Deferred Trueup EffectiveIncomeTaxRateReconciliationReturnToProvisionAndDeferredTrueup	0.0011
CY2020	kmph	Effective Income Tax Rate Reconciliation State And Local Income Taxes Tax Credit Research Percent EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxesTaxCreditResearchPercent
CY2020	kmph	Effective Income Tax Rate Reconciliation Warrant Liabilities Increase Decrease EffectiveIncomeTaxRateReconciliationWarrantLiabilitiesIncreaseDecrease	-0.003
CY2020	kmph	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment	-159000
CY2019	kmph	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment	1749000
CY2020	kmph	Finance Lease Cost Total FinanceLeaseCostTotal	147000
CY2019	kmph	Finance Lease Cost Total FinanceLeaseCostTotal	163000
CY2020	kmph	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	4000
CY2019	kmph	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	4000
CY2020	kmph	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-271000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1726000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1560000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	192062000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	171258000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	2311000
CY2020	kmph	Royalty And Direct Contract Acquisition Costs RoyaltyAndDirectContractAcquisitionCosts	1305000
CY2019	kmph	Royalty And Direct Contract Acquisition Costs RoyaltyAndDirectContractAcquisitionCosts	2945000
CY2020	kmph	Supply Arrangement Automatic Renewal Period SupplyArrangementAutomaticRenewalPeriod	P2Y
CY2019	kmph	Supply Arrangement Expense SupplyArrangementExpense	3200000
CY2020	kmph	Supply Arrangement Period Of Prior Notice SupplyArrangementPeriodOfPriorNotice	P1Y
CY2020Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2579000
CY2019Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1865000
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6647000
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4911000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1174000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1140000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2442000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1681000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	700000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	700000
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1639000
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2364000
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1299000
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3555000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19119000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4322000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	767000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15564000
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1296515
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3016722
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4537321
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2271882
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4537321
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2271882
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1653425
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	0
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; text-indent: 0pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration of Credit Risk</div></div></div> <div style=" margin: 0pt; text-align: justify; text-indent: 20.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">Financial instruments that potentially expose<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions, the balances of which frequently exceed insured limits, and accounts receivable, which are concentrated amongst a limited number of customers.</div></div></div></div></div>
CY2020Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	67658000
CY2019Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	77343000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	18897000
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	33176000
CY2020	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1777437
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	68243000
CY2019Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	80199000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	458000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	540000
CY2020Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	825000
CY2019Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	266000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	70550000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	67726000
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	59050000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	56827000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5089000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4488000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6411000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	6411000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	70092000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	67186000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	476000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0026
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2265
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0082
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0218
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0005
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0351
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1700000
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y262D
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	184000
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1998000
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	96000
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1845000
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	255000
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	23000
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	40000
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	23000
CY2019	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	40000
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	194000
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	404000
CY2020Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	205000
CY2020Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	181000
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	6000
CY2020Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	18000
CY2020Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	11000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	227000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12794000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24544000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-34000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22000
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	714000
CY2019	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1725000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	931000
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3789000
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	140000
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-798000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-160000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-544000
CY2020	us-gaap	Interest Expense InterestExpense	4785000
CY2019	us-gaap	Interest Expense InterestExpense	4858000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	78000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	5362000
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1158000
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	359000
CY2020	us-gaap	Lease Cost LeaseCost	669000
CY2019	us-gaap	Lease Cost LeaseCost	832000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2299000
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent	390000
CY2019Q4	us-gaap	Loans Payable Current LoansPayableCurrent
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	67658000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	77343000
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	391000
CY2019Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable
CY2020Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0
CY2019Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2739000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4939000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3234000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1939000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23737000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-12760000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-24522000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7185000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4207000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-5609000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-20337000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	363000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	473000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1914000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2185000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	327000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	284000
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1587000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1901000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	447000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	435000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1350000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1537000
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2020Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	225977000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	624000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	347000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	438000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	527000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	172000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	236000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	145000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	168000
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	137000
CY2019Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	184000
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	4741000
CY2019	us-gaap	Paid In Kind Interest PaidInKindInterest	1417000
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	34000
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	300000
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	84000
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1481000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1552000
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	453000
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	250000
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	781000
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2303000
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	5446000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3260000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2765000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3031000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1039000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1471000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8843000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19415000
CY2020Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	109000
CY2019Q4	us-gaap	Restricted Cash Equivalents Current RestrictedCashEquivalentsCurrent	338000
CY2020Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	53000
CY2019Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-258474000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-245714000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13288000
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12839000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	17000
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	757000
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	20000
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1852000
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	828000
CY2019	us-gaap	Severance Costs1 SeveranceCosts1
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2491000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	4410000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	191134
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	113.12
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	372
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	50659
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	92869
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	543021
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	324473
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	355785
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	100.96
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	74.60
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	163506
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	281368
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	92.53
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.22
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	85.14
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	131.61
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.21
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	103581
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y153D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	164651
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	189859
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y229D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y124D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y321D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3700000
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	4900000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	22.88
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	210000
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	232000
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition, the useful lives of property and equipment, the recoverability of long-lived assets, the incremental borrowing rate for leases, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div>
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	55000
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	48000
CY2020	us-gaap	Variable Lease Payment VariableLeasePayment	55000
CY2019	us-gaap	Variable Lease Payment VariableLeasePayment	48000
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3980975
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1853397
CY2019	kmph	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	1537000
CY2020	kmph	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	89000
CY2019	kmph	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	2185000
CY2020	kmph	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-128000
CY2019	kmph	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	309000
CY2020	kmph	Lessee Lease Option To Extend Maximum Term LesseeLeaseOptionToExtendMaximumTerm	P5Y
CY2020	kmph	Lessee Lease Option To Terminate Term LesseeLeaseOptionToTerminateTerm	P1Y
CY2020	kmph	Loss On Sublease And Disposal Of Property And Equipment LossOnSubleaseAndDisposalOfPropertyAndEquipment	251000
CY2019	kmph	Loss On Sublease And Disposal Of Property And Equipment LossOnSubleaseAndDisposalOfPropertyAndEquipment
CY2020Q4	kmph	Number Of Manufacturing Arrangements NumberOfManufacturingArrangements	1
CY2020	kmph	Operating And Capital Leases Rent Expense Net OperatingAndCapitalLeasesRentExpenseNet	600000
CY2019	kmph	Operating And Capital Leases Rent Expense Net OperatingAndCapitalLeasesRentExpenseNet	700000
CY2020Q4	kmph	Other Prepaid Expenses And Current Assets OtherPrepaidExpensesAndCurrentAssets	203000
CY2019Q4	kmph	Other Prepaid Expenses And Current Assets OtherPrepaidExpensesAndCurrentAssets	231000
CY2020	kmph	Property And Equipment Financed Under Lease Agreement PropertyAndEquipmentFinancedUnderLeaseAgreement	17000
CY2019	kmph	Property And Equipment Financed Under Lease Agreement PropertyAndEquipmentFinancedUnderLeaseAgreement
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4410000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2491000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	151000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2491000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	153000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	23000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4410000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2305000
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1656000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1248690
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2414332
CY2020Q4	us-gaap	Assets Assets	11209000
CY2019Q4	us-gaap	Assets Assets	10507000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	8382000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	6972000
CY2020Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent
CY2019Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	805000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4213000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3217000
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	540000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18000
CY2019Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	273000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	304000
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.21
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-13.23
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	123000
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.085
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	207000
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	124000
CY2019Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.077
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10816000
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2019Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7921000

Files In Submission

Name	View Source	Status
0001437749-21-005785-index-headers.html	Edgar Link	pending
0001437749-21-005785-index.html	Edgar Link	pending
0001437749-21-005785.txt	Edgar Link	pending
0001437749-21-005785-xbrl.zip	Edgar Link	pending
ex01.jpg	Edgar Link	pending
ex02.jpg	Edgar Link	pending
ex_219883.htm	Edgar Link	pending
ex_219885.htm	Edgar Link	pending
ex_219886.htm	Edgar Link	pending
ex_219887.htm	Edgar Link	pending
ex_219888.htm	Edgar Link	pending
ex_219889.htm	Edgar Link	pending
ex_227827.htm	Edgar Link	pending
ex_233334.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kmph-20201231.xml	Edgar Link	completed
kmph-20201231.xsd	Edgar Link	pending
kmph-20201231_cal.xml	Edgar Link	unprocessable
kmph-20201231_def.xml	Edgar Link	unprocessable
kmph-20201231_lab.xml	Edgar Link	unprocessable
kmph-20201231_pre.xml	Edgar Link	unprocessable
kmph20201231_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

2019 Q4 Form 10-K Financial Statement

#000143774921005785 Filed on March 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA ZEVRA THERAPEUTICS, INC. Stock $zvra

2019 Q4 Form 10-K Financial Statement

#000143774921005785 Filed on March 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra